Title:
PHARMACEUTICAL COMPOSITION FOR TREATING, PREVENTING, OR INHIBITING METASTASIS OF LUNG CANCER, COMPRISING EXOSOME AS ACTIVE INGREDIENT
Document Type and Number:
WIPO Patent Application WO/2022/045813
Kind Code:
A1
Abstract:
The present invention relates to a pharmaceutical composition for treating or preventing cancer, or inhibiting cancer metastasis, the composition comprising, as an active ingredient, an exosome that is a highly safe, cell-derived substance that can minimize the side effects of existing anticancer drugs.
Inventors:
CHO YONG WOO (KR)
MOON KYOUNG-SIK (KR)
YOO MIN HEUI (KR)
YUN YE EUN (KR)
MOON KYOUNG-SIK (KR)
YOO MIN HEUI (KR)
YUN YE EUN (KR)
Application Number:
PCT/KR2021/011483
Publication Date:
March 03, 2022
Filing Date:
August 26, 2021
Export Citation:
Assignee:
IUCF HYU ERICA CAMPUS (KR)
KOREA RES INST CHEMICAL TECH (KR)
KOREA FOOD & DRUG ADMIN (KR)
KOREA RES INST CHEMICAL TECH (KR)
KOREA FOOD & DRUG ADMIN (KR)
International Classes:
A61K35/28; A61K31/7105; A61K38/18; A61K38/20; A61P35/00; A61P35/04
Domestic Patent References:
WO2016077264A1 | 2016-05-19 | |||
WO2015154064A2 | 2015-10-08 |
Foreign References:
KR102034875B1 | 2019-10-21 | |||
KR101820264B1 | 2018-01-18 | |||
KR101804852B1 | 2017-12-07 |
Other References:
JIN JUAN, WANG YUNGUANG, ZHAO LI, ZOU WENLI, TAN MINGMING, HE QIANG: "Exosomal miRNA-215-5p Derived from Adipose-Derived Stem Cells Attenuates Epithelial–Mesenchymal Transition of Podocytes by Inhibiting ZEB2", BIOMED RESEARCH INTERNATIONAL, HINDAWI PUBLISHING CORPORATION, vol. 2020, 22 February 2020 (2020-02-22), pages 1 - 14, XP055905420, ISSN: 2314-6133, DOI: 10.1155/2020/2685305
Attorney, Agent or Firm:
PHIL & ONZI INT'L PATENT & LAW FIRM (KR)
Download PDF:
Previous Patent: THERMOELECTRIC-BASED COOLING MODULE AND COOLING DEVICE
Next Patent: STERILANT STORAGE DEVICE AND STERILIZATION DEVICE
Next Patent: STERILANT STORAGE DEVICE AND STERILIZATION DEVICE